Recent advancements in esophageal cancer treatment in Japan-Reference-Cited by-同舟云学术

Recent advancements in esophageal cancer treatment in Japan

Published:2018-05-28 Issue:4 Volume:2 Page:253-265
ISSN:2475-0328
Container-title:Annals of Gastroenterological Surgery
language:en
Short-container-title:Ann Gastroenterol Surg

Author:

Tanaka Yoshihiro¹^ORCID,Yoshida Kazuhiro¹^ORCID,Suetsugu Tomonari¹,Imai Takeharu¹,Matsuhashi Nobuhisa¹,Yamaguchi Kazuya¹

Affiliation:

1. Department of Surgical Oncology; Graduate School of Medicine; Gifu University; Gifu Japan

Publisher

Wiley

Subject

Gastroenterology,Surgery

Reference82 articles.

1. Phase II trial of docetaxel, cisplatin and fluorouracil followed by carboplatin and radiotherapy in locally advanced oesophageal cancer;Chiarion-Sileni;Br J Cancer,2007

2. Chemoradiotherapy of locally advanced esophageal cancer: long-term follow-up of a prospective randomized trial (RTOG 85-01) Radiation Therapy Oncology Group;Cooper;JAMA,1999

3. Phase II evaluation of cisplatin and 5-fluorouracil in advanced squamous cell carcinoma of the esophagus: a Japanese Esophageal Oncology Group Trial;Iizuka;Jpn J Clin Oncol,1992

4. Phase II study of cisplatin, 5-FU, and allopurinol in advanced esophageal cancer;De Besi;Cancer Treat Rep,1986

5. Randomised phase II study of cisplatin and 5-fluorouracil (5-FU) versus cisplatin alone in advanced squamous cell oesophageal cancer;Bleiberg;Eur J Cancer,1997

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Identifying intense inflammatory subtype of esophageal squamous cell carcinoma using clustering approach;General Thoracic and Cardiovascular Surgery;2024-01-31

2. Probiotic-Derived Ferrichrome Induces DDIT3-Mediated Antitumor Effects in Esophageal Cancer Cells;2024

3. Clinical impact of diarrhea during enteral feeding after esophagectomy;International Journal of Clinical Oncology;2023-11-23

4. Preoperative neoadjuvant chemoradiotherapy provides borderline resectable thoracic esophageal cancer with equivalent treatment results as clinically T3 thoracic esophageal cancer;Annals of Gastroenterological Surgery;2023-06-11

5. Prognostic impact of perioperative change in serum p53 antibody titers in esophageal squamous cell carcinoma;Esophagus;2023-05-22